Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma (Q34621127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Rolf Bjerkvig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Morgane Sanzey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Fred Fack

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Linda Stuhr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hrvoje Miletic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Daniel Stieber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Anaïs Oudin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Torfinn Taxt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Frits Thorsen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ingrid Moen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Cecilie Brekke Rygh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Mikael Johansson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Siti A Abdul Rahim

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jian Wang

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

English

0 references

publication date

14 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

Proceedings of the National Academy of Sciences of the United States of America

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

3749-3754

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

22 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Glioblastoma stem-like cells give rise to tumour endothelium.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Metabolic modulation of glioblastoma with dichloroacetate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Nestin expression in astrocytic tumors delineates tumor infiltration.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

A reproducible brain tumour model established from human glioblastoma biopsies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Antiangiogenic therapies for high-grade glioma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Cancer stem cells and angiogenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Biomarkers of response and resistance to antiangiogenic therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Pathways mediating resistance to vascular endothelial growth factor-targeted therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

VEGF-targeted therapy: mechanisms of anti-tumour activity.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Tumor cell metabolism: cancer's Achilles' heel

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Angiogenesis in brain tumours

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Angiogenesis-independent tumor growth mediated by stem-like cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Why do cancers have high aerobic glycolysis?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Estimation of volume doubling time and cell loss in an experimental rat glioma model in vivo.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048093

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

7 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

Bevacizumab and recurrent malignant gliomas: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

Automatic quantitation of localized in vivo 1H spectra with LCModel

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1014480108

Anti-angiogenesis: new concept for therapy of solid tumors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21321221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21321221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21321221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.1014480108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

21321221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321221%20AND%20SRC:MED&resulttype=core&format=json